RGC32 promotes the progression of ccRCC by activating the NF-κB/SHP2/EGFR signaling pathway
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Response gene to complement 32 (RGC32) drives clear cell Renal Cell Carcinoma (ccRCC) progression by activating the NF-κB/SHP2/EGFR pathway. This study reveals RGC32 as a potential diagnostic and prognostic biomarker for ccRCC.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- The role of Response Gene to Complement 32 (RGC32) in cancer is known, but its specific involvement in clear cell Renal Cell Carcinoma (ccRCC) is not well understood.
- Investigating novel molecular players is crucial for advancing ccRCC diagnostics and therapeutics.
Purpose Of The Study
- To elucidate the diagnostic and prognostic significance of RGC32 in clear cell Renal Cell Carcinoma (ccRCC).
- To investigate the functional role of RGC32 in ccRCC progression and its underlying molecular mechanisms.
Main Methods
- Utilized bioinformatics analysis of TCGA and GEO datasets to assess RGC32 expression and its correlation with ccRCC.
- Employed in vivo (nude mouse tumor assays) and in vitro (cell proliferation, migration, invasion, wound healing, Western blotting) experiments to evaluate RGC32 function.
- Immunohistochemistry was used to quantify RGC32 protein levels in ccRCC tissues.
Main Results
- RGC32 expression is significantly elevated in ccRCC tissues and correlates with advanced disease.
- RGC32 promotes ccRCC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
- RGC32 upregulates pro-oncogenic proteins (e.g., p-PI3K, Cyclins, MMPs, Snail, Slug) and downregulates E-cadherin via the NF-κB/SHP2/EGFR pathway.
Conclusions
- RGC32 plays a critical role in ccRCC pathogenesis and progression.
- RGC32, through activation of the NF-κB/SHP2/EGFR pathway, represents a potential therapeutic target and prognostic biomarker for ccRCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...